Skip to main content
. 2003 Mar;77(5):2859–2865. doi: 10.1128/JVI.77.5.2859-2865.2003

TABLE 1.

Effects of sCD4-17b against genetically diverse HIV-1 isolates

Expta Isolate Cladeb Phenotype (coreceptor usage)b,c % Neutralization by sCD4-17b at:
6.4 nM 32 nM
1 Ba-L B NSI (R5) 94 98
LAV B SI (X4) 50 75
2 92RW023 A NSI (R5) 0 0
Ba-L B NSI (R5) 26 99
91US054 B ns 0 0
92US714 B NSI (R5) 0 80
92US076 B SI (R5X4) 11 84
93IN905 C NSI (R5) 7 6
92UG024 D SI (X4) 0 65
93TH073 E NSI (R5) 0 0
93BR029 F NSI (R5) 14 0
a

In experiment 1, viruses were preincubated with the indicated concentrations of sCD4-17b in medium and assayed for infectivity, by using MAGI-CCR5 cells for Ba-L and MAGI cells for LAV. The numbers of blue cells per well in untreated controls were 350 for Ba-L and 300 for LAV. In experiment 2, viruses were preincubated with the indicated concentrations of affinity chromatography-enriched sCD4-17b and assayed for infectivity by using MAGI-CCR5 cells. For the different viruses, the numbers of blue cells per well in the untreated controls ranged from 50 to 475.

b

Clade and coreceptor usage phenotypes are as specified in the AIDS Research and Reference Reagent Program catalogue.

c

ns, not specified.